Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
New Pediatric Labeling Information Database - Detail
FDA Home
Pediatrics
New Pediatric Labeling Information Database
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Pediatric Labeling Date:
05/11/2001
Trade Name:
Agenerase Capusles and Oral Solution
Generic Name or Proper Name (*):
amprenavir
Indications Studied:
HIV
Label Changes Summary:
Approved for use in combination with other antiretroviral agents; new labeling provides information about the effects of drug-drug interaction
Product Labeling:
Labeling
Pediatric Rule (R):
R
Sponsor:
GlaxoSmithKline
NNPS:
FALSE'
Therapeutic Category:
Antiviral
-
-